World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
44145
World Ranking
10687
National Ranking
5494

Overview

Robert S. Rosenson is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research is primarily rooted in the field of Medicine, with a significant focus on Surgery, Cardiology and Cardiovascular Medicine, and Endocrinology, Diabetes and Metabolism. Additional areas of expertise include Economics and Econometrics as well as Cancer Research.

The scientist's work covers a range of topics, notably:

  • Lipoproteins and Cardiovascular Health
  • Lipid metabolism and disorders
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cancer, Lipids, and Metabolism
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy
  • Liver Disease Diagnosis and Treatment

The research is frequently published in notable venues including:

  • Journal of the American College of Cardiology
  • Circulation
  • Journal of clinical lipidology
  • Cardiovascular Drugs and Therapy
  • European Heart Journal

Frequent collaborators in their research include Paul Muntner, Daniel Gaudet, Lisandro D. Colantonio, Sascha N. Goonewardena, and Vera Bittner.

Among recent publications authored or co-authored by Robert S. Rosenson are:

  • Evinacumab for Homozygous Familial Hypercholesterolemia, 2020, New England Journal of Medicine
  • Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease, 2022, New England Journal of Medicine
  • Evinacumab in Patients with Refractory Hypercholesterolemia, 2020, New England Journal of Medicine
  • Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US, 2021, JAMA Cardiology
  • Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia, 2020, Journal of the American College of Cardiology

Best Publications

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Antiatherothrombotic Properties of Statins Implications for Cardiovascular Event Reduction

    Robert S. Rosenson;Christine C. Tangney

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport

    Robert S. Rosenson;H. Bryan Brewer;W. Sean Davidson;Zahi A. Fayad

  • ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents

    W. Gregory Hundley;David A. Bluemke;J. Paul Finn;Scott D. Flamm

  • Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.

    Scott M. Grundy;Gloria Lena Vega;Mark E. McGovern;Brian R. Tulloch

  • ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

    Deepak L. Bhatt;James Scheiman;Neena S. Abraham;Elliott M. Antman

  • Dysfunctional HDL and atherosclerotic cardiovascular disease

    Robert S. Rosenson;H. Bryan Brewer;Benjamin J. Ansell;Philip Barter

  • Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance : The GAUSS-2 Randomized, Placebo-Controlled Phase 3 Clinical Trial of Evolocumab

    Erik Stroes;David Colquhoun;David Sullivan;Fernando Civeira

  • Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

    P J Barter;C M Ballantyne;R Carmena;M Castro Cabezas

  • HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

    Robert S. Rosenson;H. Bryan Brewer;M. John Chapman;Sergio Fazio

  • The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.

    Jean-Charles Fruchart;Frank Sacks;Michel P Hermans;Gerd Assmann

  • Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation

    Michael Pignone;Mark J. Alberts;John A. Colwell;Mary Cushman

  • Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial

    Steven E. Nissen;Erik Stroes;Ricardo E. Dent-Acosta;Robert S. Rosenson

  • Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women

    Samia Mora;James D. Otvos;Nader Rifai;Robert S. Rosenson

  • An assessment by the Statin Muscle Safety Task Force: 2014 update

    Robert S. Rosenson;Steven K. Baker;Terry A. Jacobson;Stephen L. Kopecky

  • Inhibition of proinflammatory cytokine production by pravastatin.

    Robert S Rosenson;Christine C Tangney;Larry C Casey

  • CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice: Report From the Clinical Practice Discussion Group

    Sidney C. Smith;Jeffrey L. Anderson;Richard O. Cannon;Yazid Y. Fadl

  • Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes

    Michael Pignone;Mark J. Alberts;John A. Colwell;Mary Cushman

  • ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents.

    L. Kristin Newby;Robert L. Jesse;Joseph D. Babb;Robert H. Christenson

Frequent Co-Authors

Paul Muntner
Paul Muntner University of Alabama at Birmingham
Monika M. Safford
Monika M. Safford Cornell University
Vera Bittner
Vera Bittner University of Alabama at Birmingham
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Christopher P. Cannon
Christopher P. Cannon Brigham and Women's Hospital
James A. de Lemos
James A. de Lemos The University of Texas Southwestern Medical Center
Anna F. Dominiczak
Anna F. Dominiczak University of Glasgow
Mary Cushman
Mary Cushman University of Vermont
Kiran Musunuru
Kiran Musunuru University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always require following the traditional path of medical school. Many students and professionals are pursuing related online degrees that offer flexibility, faster completion times, and alternative roles in healthcare.

For those interested in nursing, accelerated programs like the 6 month lpn program provide a quick route to enter the nursing workforce. Similarly, those aiming for advanced practice can consider the shortest pmhnp program to become a Psychiatric-Mental Health Nurse Practitioner in less time.

If healthcare administration is your focus, online learning offers affordable options. Consider enrolling in the cheapest online healthcare administration degree for undergraduate studies or the cheapest mha programs online healthcare for graduate-level opportunities.

These pathways offer cost-effective alternatives and faster entry into vital healthcare roles, expanding your career prospects beyond the scope of a traditional medical degree.

Best Scientists Citing Robert S. Rosenson

Trending Scientists